Director at the Mayo Clinic and Mayo Clinic Laboratories In Rochester, Minnesota; Associate Professor of Medicine and Laboratory Medicine, Mayo Clinic College of Medicine and Science
On December 8th, 2021 the CDC released new recommendations for preexposure prophylaxis (PrEP) for the prevention of HIV infection in the US. These new guidelines include important updates designed to help increase access to and awareness of PrEP as well as new recommendations for laboratory testing. This webinar will review these important changes and discuss how they will impact patients, clinicians, and the clinical laboratories providing results that play a critical role in this updated approach.
Learning Objectives
Outline current HIV/PrEP landscape in the US
Describe important changes in the new 2021 CDC PrEP Guidelines
Review rationale of new recommendations for NAAT in PrEP monitoring and potential impact on clinical laboratories, clinicians, and patients
Webinars will be available for unlimited on-demand viewing after live event.
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...
Please update your information
Certificate of Attendance
Thank you for choosing Labroots. Please note that a Certificate of Attendance does NOT count towards Continuing Education Credits.